Autoimmune Disease
News on research and diagnostics in autoimmune disorders including rheumatoid arthritis, lupus, multiple sclerosis, and more.
Exagen Q1 Revenues Drop 2 Percent
Testing revenues grew slightly during the quarter, driven by an increase in Avise test orders.
The Seattle-based company recently completed a strategic reorganization around its two major business areas by cutting the workforce and appointing a new CFO.
The group is developing an ELISA assay that uses phospholipids acquired by Borrelia burgdorferi, the Lyme bacterium, as biomarkers of disease.
Exagen Q4 2021 Revenues Flat as Sales of Avise Tests Rise
The firm delivered record numbers of its flagship Avise CTD tests during both the fourth quarter and full year.
The Seattle-based company recently published immune repertoire data showing the potential of T-cell receptor profiling in IBD diagnostics.